Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Shrine Longevity

Mechanistic Molecular Sciences of Biomedicines: Rapamycin & Metformin

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

In this episode of the Longevity Biosciences series, we move beyond the hype to examine the rigorous biology of the two most famous molecules in geroscience: Rapamycin and Metformin. While often discussed as tools to "hack" biological time, the data reveals a complex reality of systems-level tradeoffs, tissue-specific benefits, and the puzzling divergence between living longer and measuring "younger" on an epigenetic clock. What we cover in this deep dive: • Mechanisms of Action (MoA): We break down how Rapamycin acts as a "heavyweight hammer" on the mTORC1 pathway to favor cellular maintenance over growth, and why Metformin is considered a "metabolic whisperer" that activates AMPK to tune energy balance. • The Aging Clock Paradox: Why some studies show these drugs extending lifespan in animal models while failing to "decelerate" certain DNA methylation clocks. We explore the difference between intrinsic cellular aging and extrinsic systemic remodeling. • Growth vs. Maintenance: A detailed look at the biological cost of longevity, including the tradeoffs between muscle mass, immune resilience, and cellular repair programs. • Senescence and Inflammation: How these biomedicines interact with the "pathogenic triad" of inflammaging, immune senescence, and the accumulation of senescent cells. • The Translational Gap: Host A and Host B debate the relevance of current biomarkers and what human evidence—like the TAME trial for Metformin or the PEARL trial for Rapamycin—is actually required to prove a drug works in humans. Featured Pathways & Concepts: mTORC1/2, AMPK activation, nutrient sensing, mitophagy, proteostasis, and the 14 Hallmarks of Aging. Disclaimer: This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any new medication or intervention. Tags: Longevity, Geroscience, Rapamycin, Metformin, Aging Clocks, mTOR, AMPK, Epigenetics, Biological Age, Healthspan, Nutrient Sensing, Cellular Senescence, Inflammaging, Biomedicine, Translational Biology, PEARL Trial, TAME Trial, 14 Hallmarks of Aging

Shrine Longevity · 55 min · Source published: 2026-05-19

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…